Proposal

EQS-News: Mobile TeleSystems PJSC: IMPORTANT NOTICE TO NOTEHOLDERS

Retrieved on: 
Sunday, November 27, 2022

THIS NOTICE IS IMPORTANT AND REQUIRES THE IMMEDIATE ATTENTION OF HOLDERS.

Key Points: 
  • THIS NOTICE IS IMPORTANT AND REQUIRES THE IMMEDIATE ATTENTION OF HOLDERS.
  • THIS NOTICE CONTAINS IMPORTANT INFORMATION THAT IS OF INTEREST TO THE REGISTERED AND BENEFICIAL OWNERS OF THE NOTES.
  • IF APPLICABLE, ALL DEPOSITORIES, CUSTODIANS AND OTHER INTERMEDIARIES RECEIVING THIS NOTICE ARE REQUIRED TO EXPEDITE TRANSMISSION HEREOF TO BENEFICIAL OWNERS OF THE NOTES IN A TIMELY MANNER.
  • The distribution of this notice and the Consent Solicitation Memorandum to which it relates in certain jurisdictions may be restricted by law.

EQS-News: Mobile TeleSystems PJSC: NOTICE OF MEETING

Retrieved on: 
Sunday, November 27, 2022

MTS PJSC (the "Company") hereby requests that the holders of U.S.$500,000,000 5 per cent.

Key Points: 
  • MTS PJSC (the "Company") hereby requests that the holders of U.S.$500,000,000 5 per cent.
  • Terms not otherwise defined in this Extraordinary Resolution shall have the meaning ascribed thereto in the Consent Solicitation Memorandum dated 21 November 2022.
  • 21.11.2022 MSK Dissemination of a Corporate News, transmitted by EQS News - a company of EQS Group AG.
  • The EquityStory.RS, LLC Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Texas Pacific Land Corporation shareholder Gabi Gliksberg shares public letter to stockholders about upcoming Annual Meeting, outlines why he plans to vote against Board recommendations

Retrieved on: 
Monday, November 14, 2022

Dear Shareholders of Texas Pacific Land Corporation,

Key Points: 
  • Dear Shareholders of Texas Pacific Land Corporation,
    I am a long-time shareholder of Texas Pacific Land Corporation (NYSE: TPL) (TPL or the Company).
  • Proof of that is the victory we scored at last years annual meeting by securing passage of my declassification proposal.
  • Passage of the Companys Proposal 3 at this years annual meeting will now likely make that declassification a reality.
  • My hope is that with this bylaw change, we will reduce director entrenchment and increase Board responsiveness to stockholders.

Brookfield Renewable Announces Participation in Proposal for Origin’s Energy Markets Business

Retrieved on: 
Wednesday, November 9, 2022

Under the proposed transaction, Brookfield Renewable and its institutional partners would acquire Origins energy markets business, Australias largest integrated generation and retail company, and MidOcean would acquire Origins Integrated Gas division.

Key Points: 
  • Under the proposed transaction, Brookfield Renewable and its institutional partners would acquire Origins energy markets business, Australias largest integrated generation and retail company, and MidOcean would acquire Origins Integrated Gas division.
  • Brookfield Renewable would pursue this transaction through the Brookfield Global Transition Fund I, which is the largest fund in the world focused on the energy transition, alongside institutional partners.
  • Origins energy markets business is well positioned to play a leading role in Australias energy transition.
  • Brookfield Renewable is the flagship listed renewable power company of Brookfield Asset Management, a leading global alternative asset manager with over $750 billion of assets under management.

ReShape Lifesciences Announces $750,000 Registered Direct Offering

Retrieved on: 
Tuesday, November 8, 2022

Total gross proceeds from the offering, before deducting the placement agent's fees and other estimated offering expenses, is expected to be approximately $750,000.

Key Points: 
  • Total gross proceeds from the offering, before deducting the placement agent's fees and other estimated offering expenses, is expected to be approximately $750,000.
  • A final prospectus supplement and accompanying prospectus relating to the securities being offered in the registered direct offering will be filed with the SEC.
  • ReShape Lifesciences is America's premier weight loss and metabolic health-solutions company, offering an integrated portfolio of proven products and services that manage and treat obesity and metabolic disease.
  • These forward-looking statements and factors that may cause such differences include the satisfaction of customary closing conditions related to the offering and the expected timing of the closing of the offering.

China Index Holdings Announces Receipt of a Revised Preliminary Non-Binding Proposal and Appointment of Independent Financial Advisor to Special Committee

Retrieved on: 
Thursday, October 13, 2022

A copy of the Revised Proposal is attached hereto as Exhibit A.

Key Points: 
  • A copy of the Revised Proposal is attached hereto as Exhibit A.
  • The Revised Proposal updates the previously announced preliminary non-binding proposal letter submitted by Fang to the Company dated August 23, 2022.
  • As previously announced, the Special Committee has retained Gibson, Dunn & Crutcher LLP as its U.S. legal counsel.
  • CIH operates a leading real estate information and analytics service platform in China in terms of geographical coverage and volume of data points.

PAO Severstal: NOTICE OF MEETING

Retrieved on: 
Wednesday, October 12, 2022

In accordance with paragraph 7 (Extraordinary Resolution) of Schedule 5 (Provisions for Meetings of Noteholders) of the Trust Deed and Condition 10.1 (Meetings of Noteholders), the Extraordinary Resolution (as defined in the Amended and Restated Principal Trust Deed dated 15 March 2013, as supplemented by the Supplemental Trust Deed dated 16 September 2019 (the "Trust Deed")) shall be passed at a meeting duly convened and held in accordance with the Trust Deed by the affirmative vote of holders of Notes present in person or represented by proxy or representative owning in the aggregate not less than two-thirds in principal amount of the Notes owned by the Noteholders who are so present or represented at the Meeting or such adjourned Meeting.

Key Points: 
  • In accordance with paragraph 7 (Extraordinary Resolution) of Schedule 5 (Provisions for Meetings of Noteholders) of the Trust Deed and Condition 10.1 (Meetings of Noteholders), the Extraordinary Resolution (as defined in the Amended and Restated Principal Trust Deed dated 15 March 2013, as supplemented by the Supplemental Trust Deed dated 16 September 2019 (the "Trust Deed")) shall be passed at a meeting duly convened and held in accordance with the Trust Deed by the affirmative vote of holders of Notes present in person or represented by proxy or representative owning in the aggregate not less than two-thirds in principal amount of the Notes owned by the Noteholders who are so present or represented at the Meeting or such adjourned Meeting.
  • PAO "Severstal" (the "Company") hereby requests that the holders of U.S.$800,000,000 3.15 per cent.
  • Terms not otherwise defined in this Extraordinary Resolution shall have the meaning ascribed thereto in the Consent Solicitation Memorandum dated 12 October 2022.
  • This Extraordinary Resolution and any non-contractual obligations arising out of or in connection with it are governed by, and shall be construed in accordance with, English law.

PAO Severstal: IMPORTANT NOTICE TO NOTEHOLDERS

Retrieved on: 
Wednesday, October 12, 2022

THIS NOTICE IS IMPORTANT AND REQUIRES THE IMMEDIATE ATTENTION OF HOLDERS.

Key Points: 
  • THIS NOTICE IS IMPORTANT AND REQUIRES THE IMMEDIATE ATTENTION OF HOLDERS.
  • THIS NOTICE CONTAINS IMPORTANT INFORMATION THAT IS OF INTEREST TO THE REGISTERED AND BENEFICIAL OWNERS OF THE NOTES.
  • IF APPLICABLE, ALL DEPOSITORIES, CUSTODIANS AND OTHER INTERMEDIARIES RECEIVING THIS NOTICE ARE REQUIRED TO EXPEDITE TRANSMISSION HEREOF TO BENEFICIAL OWNERS OF THE NOTES IN A TIMELY MANNER.
  • The distribution of this notice and the Consent Solicitation Memorandum to which it relates in certain jurisdictions may be restricted by law.

Ampio Pharmaceuticals Issues Letter to Stockholders

Retrieved on: 
Tuesday, October 4, 2022

ENGLEWOOD, Colo., Oct. 4, 2022 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), today released the following letter to stockholders from its Chairman, Kevin Buchi, and Chief Executive Officer, Mike Martino.

Key Points: 
  • ENGLEWOOD, Colo., Oct. 4, 2022 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), today released the following letter to stockholders from its Chairman, Kevin Buchi, and Chief Executive Officer, Mike Martino.
  • As a result, the exchange has suspended trading of Ampio Pharmaceuticals common stockand has commenced proceedings to delist the Company from the Exchange.
  • Most importantly, the vast majority of stockholders that have voted to date support the authorization of a reverse stock-split.
  • Every stockholder's vote is important, regardless of the number of shares held.We urge Ampio stockholders to vote their proxy and approve the Proposal.

OpGen Announces Closing of $3.38 Million Registered Direct Offering

Retrieved on: 
Monday, October 3, 2022

H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.

Key Points: 
  • H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.
  • Total gross proceeds from the offering, before deducting the placement agent's fees and other estimated offering expenses, were approximately $3.38 million.
  • A final prospectus supplement and accompanying prospectus relating to the securities being offered in the registered direct offering were filed with the SEC.
  • This press release includes statements regarding the Companys use of proceeds from the registered direct offering.